Lorenzo Malatino
TitleCited byYear
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study
C Zoccali, SM Bode-Böger, F Mallamaci, FA Benedetto, G Tripepi, ...
The Lancet 358 (9299), 2113-2117, 2001
10742001
Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease
C Zoccali, F Mallamaci, G Tripepi, FA Benedetto, S Cutrupi, S Parlongo, ...
Journal of the American Society of Nephrology 13 (1), 134-141, 2002
10092002
Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease
C Zoccali, F Mallamaci, S Parlongo, S Cutrupi, FA Benedetto, G Tripepi, ...
Circulation 105 (11), 1354-1359, 2002
6192002
Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease
C Zoccali, FA Benedetto, R Maas, F Mallamaci, G Tripepi, LS Malatino, ...
Journal of the American Society of Nephrology 13 (2), 490-496, 2002
3952002
Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients
C Zoccali, F Mallamaci, FA Benedetto, G Tripepi, S Parlongo, A Cataliotti, ...
Journal of the American Society of Nephrology 12 (7), 1508-1515, 2001
3562001
Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients
F Mallamaci, C Zoccali, G Tripepi, I Fermo, FA Benedetto, A Cataliotti, ...
Kidney international 61 (2), 609-614, 2002
3522002
Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression
C Zoccali, FA Benedetto, F Mallamaci, G Tripepi, G Giacone, ...
Kidney international 65 (4), 1492-1498, 2004
3232004
Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis
C Zoccali, FA Benedetto, F Mallamaci, G Tripepi, G Giacone, A Cataliotti, ...
Journal of the American Society of Nephrology 12 (12), 2768-2774, 2001
3132001
Inflammation is associated with carotid atherosclerosis in dialysis patients
C Zoccali, FA Benedetto, F Mallamaci, G Tripepi, I Fermo, A Focà, ...
Journal of hypertension 18 (9), 1207-1213, 2000
3132000
Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients
C Zoccali, F Mallamaci, R Maas, FA Benedetto, G Tripepi, LS Malatino, ...
Kidney international 62 (1), 339-345, 2002
2662002
Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling
A Cataliotti, LS Malatino, M Jougasaki, C Zoccali, P Castellino, G Giacone, ...
Mayo Clinic Proceedings 76 (11), 1111-1119, 2001
2472001
Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage?
P Stenvinkel, C Wanner, T Metzger, O Heimbürger, F Mallamaci, G Tripepi, ...
Kidney international 62 (5), 1791-1798, 2002
2392002
Long‐term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients
G Enia, F Mallamaci, FA Benedetto, V Panuccio, S Parlongo, S Cutrupi, ...
Nephrology Dialysis Transplantation 16 (7), 1459-1464, 2001
2382001
Diagnostic potential of cardiac natriuretic peptides in dialysis patients
F Mallamaci, C Zoccali, G Tripepi, FA Benedetto, S Parlongo, A Cataliotti, ...
Kidney international 59 (4), 1559-1566, 2001
1882001
Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients
C Zoccali, FA Benedetto, F Mallamaci, G Tripepi, G Giacone, A Cataliotti, ...
Journal of the American Society of Nephrology 15 (4), 1029-1037, 2004
1872004
Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients
F Mallamaci, C Zoccali, S Parlongo, G Tripepi, FA Benedetto, S Cutrupi, ...
American Journal of Kidney Diseases 40 (1), 68-75, 2002
1722002
Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD
F Mallamaci, G Tripepi, S Cutrupi, LS Malatino, C Zoccali
Kidney international 67 (6), 2330-2337, 2005
1432005
Norepinephrine and concentric hypertrophy in patients with end-stage renal disease
C Zoccali, F Mallamaci, G Tripepi, S Parlongo, S Cutrupi, FA Benedetto, ...
Hypertension 40 (1), 41-46, 2002
1402002
Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure
A Cataliotti, G Boerrigter, LC Costello-Boerrigter, JA Schirger, T Tsuruda, ...
Circulation 109 (13), 1680-1685, 2004
1392004
Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease
F Mallamaci, G Tripepi, R Maas, L Malatino, R Böger, C Zoccali
Journal of the American Society of Nephrology 15 (2), 435-441, 2004
1112004
The system can't perform the operation now. Try again later.
Articles 1–20